	PAREXEL announced the continued expansion of its clinical trial site alliance network, an extensive network of investigator sites and 

SMOs) that enables PAREXEL to quickly access and enroll patient populations for clients’ clinical trials worldwide.   

	To address challenges in patient recruitment, PAREXEL developed its Site Alliance network, currently consisting of more than 180 members plus several SMOs, together providing access to approximately 6,000 investigators worldwide. The SMOs alone have a combined database of 7.5 million patients in more than 25 countries. The network is currently in all the major regions where PAREXEL runs clinical trials, and is expanding to 200 sites. The network’s size and scope fosters strategic collaboration between PAREXEL and sites on behalf of clients and ensures quality across multiple sites.

News

Global network accelerates patient recruitment and clinical trial start-up times